ATLAS CAPITAL ADVISORS INC.

Position in ZTS — Zoetis Inc.

CIK 1434165 JACKSON, WY

Position in ZTS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,006

-$43,677 QoQ

Shares Held

-96.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1,364

of 1,408 holders

Holding Since

Mar 2021

21 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ATLAS CAPITAL ADVISORS INC. holds $1,827,271 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	27,453	$930,107
2	VTRS	Viatris Inc	51,227	$813,484
3	NBIX	Neurocrine Biosciences Inc	376	$63,371
4	HLN	Haleon plc	2,069	$19,303
5	ZTS	Zoetis Inc. This page	14	$1,006

21 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,006	14	-96.3%	Shares	Sole	2026-08-13
2026-03-31	$44,683	378	+2600.0%	Shares	Sole	2026-05-11
2025-12-31	$1,761	14	0.0%	Shares	Sole	2026-02-13
2025-06-30	$2,183	14	0.0%	Shares	Sole	2025-08-12
2025-03-31	$2,305	14	0.0%	Shares	Sole	2025-05-12
2024-12-31	$2,281	14	0.0%	Shares	Sole	2025-02-12
2024-09-30	$2,735	14	0.0%	Shares	Sole	2024-11-05
2024-06-30	$2,427	14	0.0%	Shares	Sole	2024-07-30
2024-03-31	$2,368	14	0.0%	Shares	Sole	2024-04-15
2023-12-31	$2,763	14	0.0%	Shares	Sole	2024-02-15
2023-09-30	$2,435	14	0.0%	Shares	Sole	2023-11-14
2023-06-30	$2,410	14	0.0%	Shares	Sole	2023-08-15
2023-03-31	$2,330	14	0.0%	Shares	Sole	2023-05-16
2022-12-31	$2,051	14	0.0%	Shares	Sole	2023-02-15
2022-09-30	$2,076	14	-81.1%	Shares	Sole	2022-11-08
2022-06-30	$12,719	74	0.0%	Shares	Sole	2022-08-16
2022-03-31	$13,955	74	0.0%	Shares	Sole	2022-05-11
2021-12-31	$18,058	74	0.0%	Shares	Sole	2022-02-01
2021-09-30	$14,366	74	0.0%	Shares	Sole	2021-10-28
2021-06-30	$13,790	74	+23.3%	Shares	Sole	2021-07-30
2021-03-31	$9,448	60	—	Shares	Sole	2021-05-10
No filing history on record for this holder in this stock.